Target intelligence / Profile preview

POM121 transmembrane nucleoporin-like 12 (POM121L12)

Target
POM121L12
Molecular classification
Other (Structural constituent of nuclear pore complex), Nucleoporin, Transmembrane protein
01

Overview

POM121 transmembrane nucleoporin-like 12 (POM121L12) is a member of the nucleoporin family, classified as a transmembrane glycoprotein and a predicted structural component of the nuclear pore complex (NPC)[2][4][6]. It shares similarity with the canonical POM121 protein, which is an essential membrane-anchored nucleoporin necessary for the assembly and function of NPCs, mediating regulated transport between the nucleus and cytoplasm[4][6]. The specific biological functions and disease associations of POM121L12 remain largely uncharacterized, but gene ontology annotations indicate it likely contributes structurally to the NPC[4]. No validated roles as a therapeutic target, nor evidence for interacting drugs, biomarker utility, or specific safety concerns, have been described for POM121L12[2][4][6][8]. While perturbations in POM121L12 gene expression have been noted across diverse datasets, this reflects general functional association data and does not suggest a defined therapeutic application[2].

Other names
POM121-like protein 12DKFZp564N2472POM121 membrane glycoprotein-like 12P1L12_HUMAN
02

Biological functions

Structural constituent of nuclear poreLikely involved in nuclear-cytoplasmic transport (by analogy to other POM121 family members)
03

Disease associations

Other (No direct associations or detailed roles in major disease categories are established for POM121L12. Note: Data on disease links pertains primarily to the canonical POM121, not POM121L12 specifically[4].)

Beyond the preview

Go deeper on POM121 transmembrane nucleoporin-like 12 (POM121L12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POM121 transmembrane nucleoporin-like 12 (POM121L12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call